SeraCare Announces Receipt of Notice from NASDAQ
December 23 2005 - 4:26PM
PR Newswire (US)
OCEANSIDE, Calif., Dec. 23 /PRNewswire-FirstCall/ -- SeraCare Life
Sciences, Inc. (NASDAQ:SRLSENASDAQ:SRLS), today announced that due
to its failure to timely file a Form 10-K for its fiscal year ended
September 30, 2005, in violation of NASDAQ Marketplace Rule
4310(c)(14), it has received a staff determination letter from
NASDAQ indicating that the Company's securities will be delisted
from NASDAQ at the opening of business on December 30, 2005, unless
the Company requests a hearing before NASDAQ's Listing
Qualifications Panel to review NASDAQ's decision to delist the
Company's securities. The Company intends to request such a
hearing. The Company's securities will remain listed on NASDAQ
pending the outcome of such hearing. The Company was advised by
NASDAQ in such letter that the Company's trading symbol will change
from "SRLS" to "SRLSE" commencing at the opening of business on
December 23, 2005. About SeraCare Life Sciences SeraCare Life
Sciences Inc. is a manufacturer and provider of biological products
and services to diagnostic, therapeutic, drug discovery, and
research organizations. The Company's offerings include
plasma-based therapeutic products, diagnostic products and
reagents, cell culture products, specialty plasmas, in vitro
stabilizers, and the SeraCare BioBank(TM), a proprietary database
of medical information and associated blood, plasma, DNA and RNA
samples. Headquartered in Oceanside, CA, SeraCare conducts business
throughout the world, and is traded on the NASDAQ national stock
market under the symbol SRLSE. For additional information about
SeraCare Life Sciences Inc., please visit the Company's web site at
http://www.seracare.com/. Safe Harbor Forward Looking Statements
Certain statements contained in this press release may be deemed to
be forward looking statements under federal securities laws, and
the Company intends that such forward looking statements be subject
to the safe harbor created thereby. The Company cautions that these
statements are qualified by important factors that could cause
actual results to differ materially from those reflected by the
forward looking statements. Information on factors that could
affect the Company and its financial results is included in the
Company's report on Form 10-K for the year ended September 30, 2004
filed with the Securities and Exchange Commission (SEC) as well as
the Company's other public filings with the SEC. The Company
undertakes no obligation to publicly update or revise any forward
looking statements, whether as a result of new information, future
events or otherwise. DATASOURCE: SeraCare Life Sciences, Inc.
CONTACT: Tim Ryan of The Trout Group, +1-212-477-9007x24, , for
SeraCare Life Sciences, Inc. Web site: http://www.seracare.com/
Copyright